4//SEC Filing
LEONARD JOHN M 4
Accession 0000950170-25-001236
CIK 0001652130other
Filed
Jan 2, 7:00 PM ET
Accepted
Jan 3, 4:30 PM ET
Size
18.0 KB
Accession
0000950170-25-001236
Insider Transaction Report
Form 4
LEONARD JOHN M
DirectorPresident and CEO
Transactions
- Exercise/Conversion
Restricted Stock Unit
2025-01-01−7,850→ 0 totalFrom: 2025-01-01Exp: 2031-03-02→ Common Stock (7,850 underlying) - Exercise/Conversion
Common Stock
2025-01-01+7,850→ 967,922 total
Holdings
- 58,415(indirect: By Trust)
Common Stock
Footnotes (3)
- [F1]Restricted stock units ("RSUs") convert into common stock on a one-for-one basis.
- [F2]Shares held by the John M. Leonard 2015 Irrevocable Trust.
- [F3]On March 3, 2021, the reporting person was granted 31,394 RSUs pursuant to the Intellia Therapeutics, Inc. Amended and Restated 2015 Stock Option and Incentive Plan. Each RSU represents a contingent right to receive one share of the Company's common stock upon vesting, with 25% of the RSU vesting on January 1, 2022 and the remaining awards vesting as to 25% in substantially equal annual installments thereafter.
Documents
Issuer
Intellia Therapeutics, Inc.
CIK 0001652130
Entity typeother
Related Parties
1- filerCIK 0001563584
Filing Metadata
- Form type
- 4
- Filed
- Jan 2, 7:00 PM ET
- Accepted
- Jan 3, 4:30 PM ET
- Size
- 18.0 KB